Cardiff Oncology, Inc.CRDFNASDAQ
Loading
Year-over-year debt growth rate
Latest
-17.62%
↓ 441% vs avg
Percentile
P13
Within normal range
Streak
15 qtr
Consecutive declineDecelerating
Average
5.16%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -17.62% |
| Q3 2025 | -14.77% |
| Q2 2025 | -12.61% |
| Q1 2025 | -10.97% |
| Q4 2024 | -9.67% |
| Q3 2024 | -8.52% |
| Q2 2024 | -7.71% |
| Q1 2024 | -7.07% |
| Q4 2023 | -6.36% |
| Q3 2023 | -5.79% |
| Q2 2023 | -5.47% |
| Q1 2023 | -5.08% |
| Q4 2022 | -4.67% |
| Q3 2022 | -4.30% |
| Q2 2022 | -4.09% |
| Q1 2022 | -0.51% |
| Q4 2021 | -5.05% |
| Q3 2021 | 705.15% |
| Q2 2021 | -36.55% |
| Q1 2021 | -26.01% |
| Q4 2020 | -37.74% |
| Q3 2020 | -13.44% |
| Q2 2020 | 6.06% |
| Q1 2020 | -11.94% |
| Q4 2019 | -10.41% |
| Q3 2019 | -9.27% |
| Q2 2019 | -8.29% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | -100.00% |
| Q1 2018 | -11.79% |
| Q4 2017 | -10.49% |
| Q3 2017 | -9.52% |
| Q2 2017 | -90.08% |
| Q1 2017 | 0.22% |
| Q4 2016 | 0.85% |
| Q3 2016 | 8.03% |
| Q2 2016 | -6.44% |
| Q1 2016 | -1.51% |